Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer

BACKGROUND: Although capecitabine has theoretical advantages in the pharmacokinetics, such as higher intratumoral and lower systemic concentration, relative to bolus 5-fluorouracil (5-FU), outcomes of chemoradiotherapy (CRT) with capecitabine or bolus 5-FU have not been directly compared in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeon-Joo, Lee, Woo Jin, Woo, Sang Myung, Kim, Tae Hyun, Han, Sung-Sik, Kim, Bo Hyun, Moon, Sung Ho, Kim, Sang Soo, Koh, Young Hwan, Park, Sang-Jae, Kim, Joo-Young, Kim, Dae Yong, Park, Joong-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702484/
https://www.ncbi.nlm.nih.gov/pubmed/23822606
http://dx.doi.org/10.1186/1748-717X-8-160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702484/
https://www.ncbi.nlm.nih.gov/pubmed/23822606
http://dx.doi.org/10.1186/1748-717X-8-160

Ejemplares similares